TITLE

Smoking Cessation and Psychiatric Effects

PUB. DATE
September 2009
SOURCE
Travel Medicine Advisor;Sep2009 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article announces the product warning requirement imposed by the U.S. Food and Drug Administration (FDA) regarding the risk of serious neuropsychiatric symptoms related to the use of smoking cessation drugs varenicline and bupropion. The new box warning advises patients to stop taking the drugs immediately if they develop changes in behavior including hostility, agitation, depression and suicidal thoughts. The article claims that psychiatric patients are of particular risk.
ACCESSION #
43828769

 

Related Articles

  • Smoking Cessation and Psychiatric Effects.  // Infectious Disease Alert;Sep2009 Pharmacology Watch, p2 

    The article offers advice from the U.S. Food and Drug Administration (FDA) regarding smoking cessation drugs varenicline (Chantix) and bupropion (Zyban, Wellbutrin) and their side effects. The FDA required a new box warnings emphasizing the risk of serious neuropsychiatric symptoms associated...

  • Smoking Cessation and Psychiatric Effects. Elliott, William T. // Primary Care Reports;Sep2009 Supplement, p2 

    The article reports that the Food and Drug Administration (FDA) in the U.S. has required box warnings for smoking cessation drugs varenicline, Chantix® and bupropion, Zyban® and Wellburtin®, because of risk of serious neuropsychiatric symptoms. According to the FDA, patients should stop...

  • Smoking Cessation and Psychiatric Effects.  // Neurology Alert;Sep2009 Pharmacology Watch, p2 

    The article reports that the U.S. Food and Drug Administration (FDA) requires new box warnings on smoking cessation drugs varenicline and bupropion to indicate the risk of serious neuropsychiatric symptoms. It also advises patients to immediately stop using the drug when behavioral changes,...

  • Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study.  // British Dental Journal;2/23/2013, Vol. 214 Issue 4, p169 

    Stopping smoking reduces anxiety.

  • US FDA alerts about revisions to varenicline prescribing information.  // Reactions Weekly;2/9/2008, Issue 1188, p2 

    The article reports on an alert for healthcare professionals and a Public Health Advisory issued by the U.S. Food and Drug Administration (FDA) to provide information on important revisions to the Warnings and Precautions sections of Chantix prescribing information regarding serious...

  • THINKING OUTSIDE THE BLACK BOX: THE RELATIVE RISK OF SUICIDALITY IN ANTIDEPRESSANT USE. Goldstein, Elizabeth A.; Ruscio, John // Scientific Review of Mental Health Practice;2009, Vol. 7 Issue 1, p3 

    The Food and Drug Administration issued a black box warning in response to concerns that antidepressants may increase the risk or suicidality in children and young adults. In the effort to weigh the benefits and risks of anti-depressants, numerous methodological challenges preclude the...

  • FDA studies effectiveness, benefits of long-term smoking-cessation therapy. Johnsen, Michael // Drug Store News;12/13/2010, Vol. 32 Issue 15, p46 

    The article reports on the study conducted by the Food and Drug Administration (FDA) regarding the effectiveness and benefits of long-term use of nicotine-replacement therapy (NRT) products to maintain the smoking-cessation therapy.

  • Wait, Smoking Is Dangerous? Sullum, Jacob // Reason;Mar2011, Vol. 42 Issue 10, p80 

    The article focuses on the U.S. Food and Drug Administration's proposal to use bigger and illustrated cigarette warning labels to encourage people to quit smoking.

  • Affective and Cognitive Mediators of the Impact of Cigarette Warning Labels. Emery, Lydia F.; Romer, Daniel; Sheerin, Kaitlin M.; Jamieson, Kathleen Hall; Peters, Ellen // Nicotine & Tobacco Research;Mar2014, Vol. 16 Issue 3, p263 

    Introduction: Research conducted by the U.S. Food and Drug Administration to select graphic warning labels for cigarette packs has been challenged as inadequate for demonstrating effects on smokers’ beliefs about smoking. The present study tested the prediction that warnings alter risk...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics